2018 was a year of uncertainty due to political and economic developments in Mexico and abroad. Although the dust has somewhat settled and with a new government for the next six years, the healthcare sector still has only an idea of the policies to be implemented. This chapter will analyze healthcare sector's challenges and how it is preparing for them, including subpar government health spending, a rise in chronic conditions and high out-of-pocket expenditure from the point of view of governments, organizations and international bodies.
While often seen as the domain of hospitals, healthcare requires a comprehensive outlook that is patient-centric and involves all care providers. Hospitals, clinics, doctors and patient associations need to engage in continuous communication to ensure that everyone stays up to date on care standards. This chapter will analyze how care institutions, providers and doctors are addressing each other’s needs to maximize resources, create much-needed efficiencies and improve access to healthcare.
Mexico is already a key player in the manufacture and export of pharmaceuticals yet getting innovative medicines into the hands of the local population remains a challenge. One key segment that also remains out of reach for the country’s professionals is clinical research. Despite solid regulations, well-trained researchers and a diverse and appealing population demographics, very little clinical research are done in the country. This chapter will analyze the market opportunities and challenges for clinical research and innovative medicines.
Stronger regulations concerning the manufacture of generics alongside the high costs of patented medications have led to a boom in Mexican generics market, which now accounts for the majority of product sales in terms of volume. While this market is expected to continue growing, it is not without its challenges. This chapter will analyze market opportunities for generics and how companies can differentiate themselves from one another, while also looking into the increasingly competitive landscape.
Technology is increasingly penetrating every economic sector and healthcare is no exception. Its defenders are looking to increasingly integrated healthcare solutions that connect every aspect of care while some of the more traditional parties seem reluctant to integrate new technologies. Technology advances at a rapid pace, raising the question of legislation and the ability of government regulators to keep pace. This chapter will analyze how companies are disrupting healthcare practices, as well as its advantages and disadvantages.
Mexico is the world’s eighth-largest exporter of medical devices and No. 1 in Latin America. The country is becoming an exporting powerhouse due to its labor force, ideal location and lower manufacturing costs. However, many Mexicans still do not have access to these products that include everything from wearables to sophisticated machinery. This chapter will explore Mexico’s capabilities and industry outlook as a medical devices exporter. It will also analyze the current market and technology trends and look at how to address barriers to access.
The introduction of new sales channels for medications such as drug sales at retail stores and through online platforms is leading traditional pharmacies to increasingly differentiate themselves in order to stand out and maintain their market share. It is also leading them to take an increasingly important and comprehensive role in healthcare, like including doctors. This chapter aims to identify the main areas of opportunity and overlooked niches for the development and commercialization of medicines and medical supplies in Mexico.
Mexican production of medications has grown significantly since the elimination of the plant requirement for foreign drugs and the adoption of generics gave local manufacturers room for growth. International companies continue to manufacture in the country as its low-cost labor and strict regulations remain attractive. This chapter will analyze the local capabilities for medication manufacturing in the country and their supply chain, while also discussing the challenges that companies face in Mexico and the region.
Along with health industries supply chain, logistics operators play an essential role in ensuring that medications arrive safely and unmodified in the hands of patients to ensure they maintain their efficacy and potency. However, the complexity of this job increases due to Mexico's infrastructure and safety concerns. This chapter will analyze the main efforts being made to ensure the safe and fast management of medications. Leaders of the industry’s key companies also provide their insights, from distributors to operators and integrators.
Among the many challenges the healthcare sector faces, there is a growing need for trained professionals. This is expected to become even more pronounced as the population ages and gains weight. The country also needs to train and attract the necessary human talent that will help it achieve its health goals in collaboration with universities, the government, recruiters and the industry. This chapter provides an overview of the talent deficit on both, skills and numbers and how industry entities are working to address this vital need.
With Mexico’s growing obesity epidemic, many are exhorting individuals to empower themselves and take their health into their own hands in every aspect of their lives. This will require a comprehensive approach that involves not just individuals at any state of their lives but the participation of product and service providers from many areas that are often overlooked but that are still essential to care, including physical activity and skin, eye and dental care. This chapter aims to show how they foster health proactive health dynamics.
For Mexico, 2018 was a year of change in many aspects due to federal and state elections. A new government is implementing changes at all levels as newly appointed representatives take charge to achieve their objectives in healthcare. During this period, national and international companies will require a solid understanding of the regulatory environment that only legislative experts can provide. This chapter will analyze the coming changes in the regulatory landscape and what companies must do to adapt under this panorama.
Increasing access to care remains one of the largest challenges of the Mexican healthcare sector, which has millions of individuals without any care provider and many facing long waiting periods and longer distances to travel to access services. Insurance companies and others see an opportunity to make inroads in a country that traditionally spurns coverage and fill the gaps to protect those who have fallen through the cracks of healthcare coverage. This chapter will analyze strategies to increase access to care through insurance and others.
Mexico is now in the midst of an epidemiological transition that is expected to change Mexican lifestyles and healthcare needs for years to come. New technological trends and national and international trade policies and agreements are continuously changing healthcare operations, while the new federal administration will have six years to put its stamp on the sector. This chapter will analyze the trends that could alter the healthcare environment in the years to come through interviews with those who are making waves.
FOLLOW US IN:
WELCOME TO MHR 2018
Mexico Health Review provides a comprehensive overview of the Mexican healthcare industry, including the latest trends and developments, business strategies, operational and logistic barriers, legal and regulatory issues, and main investment opportunities. This annual publication comprises more than 350 pages of relevant industry information based on more than 175 interviews with the industry leaders and policy makers who are driving the growth and development of the sector.
Mexico Health Review takes advantage of different platforms – print, digital, and iPad – to reach the key players in the healthcare industry both in Mexico and the rest of the world. This publication facilitates the exchange of information among the most influential business leaders in the industry and this way it becomes an instrument for growth.
THIS IS HOW WE DO IT
- Cutting-edge interviews with the key decision makers in the Mexican healthcare industry, the political leaders and main policy makers of the sector
- Dedicated editorial team combining in-depth knowledge of the sector, large experience in covering Mexico’s healthcare industry, and a thorough understanding of global trends and technological advances
- Editorial cooperation with the leading voices of the Mexican healthcare industry
- Regular updates on trending topics through our blog
- Uniquely customized readership that ensures targeted and unprecedented reach among key decision makers in Mexico and around the world
THE STATE OF MEXICO’S HEALTHCARE INDUSTRY
As 2016 turned the corner into a new year, macroeconomic uncertainty kept the world – and the global business community – on tenterhooks. The Mexican health industry cast a wary eye on events north of the border that were impacting the local exchange rate while also focusing treatment efforts on obesity and diabetes, which continued to top the country’s major health concerns. Considered as epidemics by the government, steps are being taken to eradicate these diseases in the country, especially through prevention. However, universal access to health, a key to promoting prevention in an increasingly aging population that is not accustomed to continuous medical checkups, remains an illusive ideal in the face of a fractured Mexican health system and the large number of people who continue to work informally, which complicates their access to a system marked by budget cuts. In this context, collaboration between the public and private sectors is vital for improving quality of life.
In the private sector, global economic uncertainty, and the election of US President Donald Trump, led large pharmaceutical companies to begin 2017 with some misgivings about peso volatility versus the two major currencies: the dollar and the euro, although initial fears faded as stability returned to the domestic currency. In fact, most continue to report growth and show a commitment to the development of health in Mexico through investments in areas such as clinical research, an area in which the country aspires to become a referent.
The health sector, which represents around 6 percent of the country’s GDP, continues to be a strategic industry for Mexico, a country blessed by an ideal geographical location, neighbor to the US and gateway to Latin America for many companies, and a diverse population. Mexico Health Review 2017 offers key insight into the challenges and the opportunities the industry continues to face, providing top-shelf interviews, analyses, insights and infographics. Mexico Health Review 2017 is essential to understanding the state of the health industry in Mexico today and for the path ahead.